MannKind Profit Margin 2006-2021 | MNKD
Current and historical gross margin, operating margin and net profit margin for MannKind (MNKD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. MannKind net profit margin as of September 30, 2021 is -97.43%.
|MannKind Annual Profit Margins
|MannKind Quarterly Profit Margins
||Medical - Biomedical and Genetics
Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.